Shares of hVIVO plc (LON:HVO – Get Free Report) fell 6.8% during trading on Thursday . The company traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). 2,518,262 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).
hVIVO Price Performance
The firm has a market capitalization of £129.95 million, a price-to-earnings ratio of 636.67 and a beta of 0.97. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The company’s 50 day moving average price is GBX 23.20 and its 200 day moving average price is GBX 26.66.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than hVIVO
- What is Put Option Volume?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- What is a Special Dividend?
- Nebius Group: The Rising Star in AI Infrastructure
- What is the Dow Jones Industrial Average (DJIA)?
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
